Article
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.
Molecular & cellular proteomics : MCP - 1 Feb 2013
Demory Beckler Michelle, Higginbotham James N, Franklin Jeffrey L, Ham Amy-Joan, Halvey Patrick J, Imasuen Imade E, Whitwell Corbin, Li Ming, Liebler Daniel C, Coffey Robert J
Abstract excerpt
Activating mutations in KRAS occur in 30% to 40% of colorectal cancers. How mutant KRAS alters cancer cell behavior has been studied intensively, but non-cell autonomous effects of mutant KRAS are less understood. We recently reported that exosomes isolated from mutant KRAS-expressing colon cancer cells enhanced the invasiveness of recipient cells relative to exosomes purified from wild-type KRAS-expressing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
